BioCentury | Nov 30, 2018
Company News

Alvotech grants Fuji rights to biosimilar portfolio in Japan

...Alvotech ehf (Reykjavik, Iceland) granted Fuji Pharma Co. Ltd. (Tokyo:4554) exclusive rights to commercialize Alvotech's biosimilar portfolio in Japan...
...not respond to inquiries. Alvotech ehf, Reykjavik, Iceland Fuji Pharma Co. Ltd. (Tokyo:4554), Tokyo, Japan Business: Biosimilars Shannon Lehnbeuter Alvotech ehf Fuji Pharma Co. Ltd....
BioCentury | Jul 6, 2017
Company News

Mithra grants Fuji commercialization rights to Donesta in Asia

...Mithra Pharmaceuticals S.A. (Euronext:MITRA) granted Fuji Pharma Co. Ltd. (Tokyo:4554) exclusive rights to commercialize Donesta in Japan and in...
...respond to inquiries. Mithra Pharmaceuticals S.A. (Euronext:MITRA), Liege, Belgium Fuji Pharma Co. Ltd. (Tokyo:4554), Tokyo, Japan Business: Endocrine/Metabolic Shannon Lehnbeuter Fuji Pharma Co. Ltd. Mithra...
BioCentury | Mar 11, 2013
Clinical News

Filgrastim NK regulatory update

...approved Filgrastim BS ( FSK0808 ) from Mochida Pharmaceutical Co. Ltd. (Tokyo:4534, Tokyo, Japan) and Fuji Pharma Co. Ltd....
BioCentury | Mar 5, 2013
Company News

Japan approves another biosimilar G-CSF

...November, Japan approved Filgrastim BS ( FSK0808 ) from Mochida Pharmaceutical Co. Ltd. (Tokyo:4534) and Fuji Pharma Co. Ltd....
BioCentury | Jan 2, 2012
Clinical News

G-CSF regulatory update

...Mochida and partner Fuji Pharma submitted a regulatory application in Japan for FSK0808, a biosimilar of G-CSF...
...the first application for a biosimilar version of G-CSF in Japan. Details were not disclosed. Fuji Pharma Co. Ltd....
BioCentury | Dec 28, 2011
Company News

Mochida, Fuji submit application in Japan for G-CSF biosimilar

...Mochida Pharmaceutical Co. Ltd. (Tokyo:4534) and partner Fuji Pharma Co. Ltd. (Osaka:4554; JASDAQ:4554) submitted a regulatory application in Japan...
Items per page:
1 - 6 of 6
BioCentury | Nov 30, 2018
Company News

Alvotech grants Fuji rights to biosimilar portfolio in Japan

...Alvotech ehf (Reykjavik, Iceland) granted Fuji Pharma Co. Ltd. (Tokyo:4554) exclusive rights to commercialize Alvotech's biosimilar portfolio in Japan...
...not respond to inquiries. Alvotech ehf, Reykjavik, Iceland Fuji Pharma Co. Ltd. (Tokyo:4554), Tokyo, Japan Business: Biosimilars Shannon Lehnbeuter Alvotech ehf Fuji Pharma Co. Ltd....
BioCentury | Jul 6, 2017
Company News

Mithra grants Fuji commercialization rights to Donesta in Asia

...Mithra Pharmaceuticals S.A. (Euronext:MITRA) granted Fuji Pharma Co. Ltd. (Tokyo:4554) exclusive rights to commercialize Donesta in Japan and in...
...respond to inquiries. Mithra Pharmaceuticals S.A. (Euronext:MITRA), Liege, Belgium Fuji Pharma Co. Ltd. (Tokyo:4554), Tokyo, Japan Business: Endocrine/Metabolic Shannon Lehnbeuter Fuji Pharma Co. Ltd. Mithra...
BioCentury | Mar 11, 2013
Clinical News

Filgrastim NK regulatory update

...approved Filgrastim BS ( FSK0808 ) from Mochida Pharmaceutical Co. Ltd. (Tokyo:4534, Tokyo, Japan) and Fuji Pharma Co. Ltd....
BioCentury | Mar 5, 2013
Company News

Japan approves another biosimilar G-CSF

...November, Japan approved Filgrastim BS ( FSK0808 ) from Mochida Pharmaceutical Co. Ltd. (Tokyo:4534) and Fuji Pharma Co. Ltd....
BioCentury | Jan 2, 2012
Clinical News

G-CSF regulatory update

...Mochida and partner Fuji Pharma submitted a regulatory application in Japan for FSK0808, a biosimilar of G-CSF...
...the first application for a biosimilar version of G-CSF in Japan. Details were not disclosed. Fuji Pharma Co. Ltd....
BioCentury | Dec 28, 2011
Company News

Mochida, Fuji submit application in Japan for G-CSF biosimilar

...Mochida Pharmaceutical Co. Ltd. (Tokyo:4534) and partner Fuji Pharma Co. Ltd. (Osaka:4554; JASDAQ:4554) submitted a regulatory application in Japan...
Items per page:
1 - 6 of 6